FIORE, DANILO
 Distribuzione geografica
Continente #
NA - Nord America 471
EU - Europa 266
AS - Asia 166
AF - Africa 12
Totale 915
Nazione #
US - Stati Uniti d'America 453
IT - Italia 112
SG - Singapore 74
CN - Cina 63
NL - Olanda 44
DE - Germania 35
FR - Francia 23
FI - Finlandia 21
CA - Canada 16
IE - Irlanda 16
VN - Vietnam 16
CI - Costa d'Avorio 10
IN - India 6
RU - Federazione Russa 6
GB - Regno Unito 4
ES - Italia 3
HK - Hong Kong 2
MX - Messico 2
PK - Pakistan 2
ZA - Sudafrica 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
RS - Serbia 1
TH - Thailandia 1
TR - Turchia 1
Totale 915
Città #
Chandler 96
Singapore 64
Santa Clara 48
Ashburn 44
Amsterdam 43
Napoli 25
Naples 21
Millbury 19
Boston 17
Dong Ket 16
Beijing 15
Ottawa 15
Princeton 12
Helsinki 10
Lawrence 9
Seattle 9
Nanjing 8
Wilmington 8
Des Moines 7
Redwood City 7
Castelvetere sul Calore 6
Jiaxing 6
Pune 6
Rome 6
Shenyang 6
Caserta 4
Nocera Inferiore 4
Tianjin 4
Moscow 3
Saint Petersburg 3
Avellino 2
Bologna 2
Crispano 2
Dallas 2
Hebei 2
Johannesburg 2
Milan 2
Nanchang 2
Sargodha 2
Shanghai 2
Verona 2
Washington 2
Évry 2
Aversa 1
Bacoli 1
Bangkok 1
Belgrade 1
Brno 1
Casoria 1
Castellammare di Stabia 1
Changchun 1
Changsha 1
Chittagong 1
Cosenza 1
Falkenstein 1
Falls Church 1
Hangzhou 1
Hidalgo 1
Jinan 1
Kronberg 1
Lappeenranta 1
Messina 1
Nigde 1
Ningbo 1
Norwalk 1
Nuremberg 1
Portici 1
Qualiano 1
San Gennaro Vesuviano 1
San Giorgio del Sannio 1
San Leandro 1
Secaucus 1
Shaoxing 1
Toronto 1
Troon 1
Valencia 1
Villaricca 1
Totale 601
Nome #
RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway 82
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS 80
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 62
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 61
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer 59
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL 58
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. 53
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b 49
Contrast-induced acute kidney injury: Potential new strategies 48
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells 47
Therapeutic strategies to prevent contrast-induced acute kidney injury 41
In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. 38
Peripheral T cell lymphomas: from the bench to the clinic 37
Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. 36
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas 36
The novel lncRNA BlackMamba controls the neoplastic phenotype of ALK− anaplastic large cell lymphoma by regulating the DNA helicase HELLS 31
Discovery and pharmacological characterization of JNJ-64619178, a novel small-molecule inhibitor of PRMT5 with potent antitumor activity 29
In Vivo and Ex Vivo Patient-Derived Tumor Xenograft Models of Lymphoma for Drug Discovery 27
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 24
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models 23
A novel jak1 mutant breast implant-associated anaplastic large cell lymphoma patient-derived xenograft fostering pre-clinical discoveries 23
Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities 18
Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death 17
Totale 979
Categoria #
all - tutte 4.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 11 1 5 0 12 9 6
2020/202152 7 0 8 1 8 7 0 2 0 0 2 17
2021/2022140 0 0 0 0 0 1 2 24 17 19 31 46
2022/2023219 22 3 7 8 40 29 0 25 34 42 8 1
2023/2024169 6 22 12 16 6 35 6 26 9 2 26 3
2024/2025184 23 43 11 9 19 79 0 0 0 0 0 0
Totale 979